ABC News: New Drug for Lost Libido
Spana hopes his company has stumbled on the holy grail of sexual dysfunction.
And how does bremelanotide work?
Spana says it activates parts of the brain that are involved in regulating normal sexual function.
He says other products on the market, such as Viagra, Cialis and Levitra, "work by affecting peripheral blood flow, [rather than] the central nervous system."
A First of a Kind for Women
Palatin Technologies, a biotech company in New Jersey, hopes to have bremelanotide on the market for men within a couple of years — and for women shortly after that.
If approved, it would be the first drug sold in the United States to specifically target lack of sexual desire in women.
It's for those experiencing serious sexual problems — women who've gone through menopause or had a hysterectomy, for instance, and lost desire as a result.
Michael Perelman, a New York City sex and marriage therapist, screened women for Palatin's human trials, and has kept an eye on the results.
"Some of the women put it in colorful language that I'm not comfortable using on television," Perelman told ABC News' "Nightline."
"But what was said was that, 'The quality of my orgasm was more the way it used to be, and I like that.' 'I had some thoughts about my husband.' 'I initiated sex with him for the first time even though I've thought about doing it for a long time.' Those were some of the things that they said," Perelman said.
If and when bremelanotide makes it to market, it will be administered as a single-use nasal spray.
That way, it goes straight to the brain and avoids being broken down in the digestive system.
Dr. Annette Shadiack, Director of Research at Palatin, says the results last six hours or eight hours, with the onset as early as 30 minutes.
Drug Abuse Concerns
But bremelanotide likely will encounter tough resistance on its way to receiving approval from the Food and Drug Administration.
Spana hopes his company has stumbled on the holy grail of sexual dysfunction.
And how does bremelanotide work?
Spana says it activates parts of the brain that are involved in regulating normal sexual function.
He says other products on the market, such as Viagra, Cialis and Levitra, "work by affecting peripheral blood flow, [rather than] the central nervous system."
A First of a Kind for Women
Palatin Technologies, a biotech company in New Jersey, hopes to have bremelanotide on the market for men within a couple of years — and for women shortly after that.
If approved, it would be the first drug sold in the United States to specifically target lack of sexual desire in women.
It's for those experiencing serious sexual problems — women who've gone through menopause or had a hysterectomy, for instance, and lost desire as a result.
Michael Perelman, a New York City sex and marriage therapist, screened women for Palatin's human trials, and has kept an eye on the results.
"Some of the women put it in colorful language that I'm not comfortable using on television," Perelman told ABC News' "Nightline."
"But what was said was that, 'The quality of my orgasm was more the way it used to be, and I like that.' 'I had some thoughts about my husband.' 'I initiated sex with him for the first time even though I've thought about doing it for a long time.' Those were some of the things that they said," Perelman said.
If and when bremelanotide makes it to market, it will be administered as a single-use nasal spray.
That way, it goes straight to the brain and avoids being broken down in the digestive system.
Dr. Annette Shadiack, Director of Research at Palatin, says the results last six hours or eight hours, with the onset as early as 30 minutes.
Drug Abuse Concerns
But bremelanotide likely will encounter tough resistance on its way to receiving approval from the Food and Drug Administration.
Comments
And in regards to supposed problems the company may have in getting that drug approved by the FDA... why? Because some people might abuse it? lol Well people will abuse ANY drug. That doesn't stop them from approving and selling medication already whoch some people abuse (way too many to list).
If the FDA doesn't approve a drug - the only drug - that effectively treats female sexual dysfunction, there will be a ton of women picketing in the streets; especially since the male equivalent (erectile dysfunction) has a variety of treatments available to them.
If you're really interested in following the progress of Bremelanotide, I'd suggest subscribing to the Bremelanotide Bulletin - they send out a newsletter link only once in a while, but it summarizes the latest news and test results at that time so we can stay uptodate.
http://www.bremolanotide.com/bremelanotide-bulletin/
Thanks again for the link to the ABC news page (are they going to show that on TV too, or have they already..?) and hopefully people research it enough on their own to make informed decisions. :)